Herlon Oliveira

Amazonia Tech Partners (ATP) is redefining the future of sustainability by blending cutting-edge technology with conservation to address some of the worlds most pressing challenges. Our mission is to restore balance to ecosystems while empowering communities and industries to thrive responsibly. We specialize in Nature-Based Solutions (NbS), delivering scalable solutions in climate resilience, food security, and energy transition. At the heart of ATP is our Agentic Crews—an advanced ecosystem of AI agents designed to monitor, verify, and execute critical processes in environmental conservation and sustainable development. These digital agents enable precise Monitoring, Reporting, and Verification (MRV) to ensure compliance and drive impact where it matters most. Our proprietary AGTX AI Platform empowers green finance by turning natural assets—like forests, soil, and water—into measurable economic value. From regenerating degraded lands to supporting agroforestry systems, we help industries align with conservation goals while boosting profitability. Through innovation and collaboration, ATP is building a greener future by harnessing technology to scale conservation efforts, accelerate restoration, and optimize the management of natural resources. Join us in transforming sustainability into a scalable reality.

CERTI is a technology-based institution, located at Florianopolis – SC, Brazil. Founded in 1984, CERTI has been operating on the concepts of quality, speed, innovation, responsibility and value delivery. CERTI has been devoted to innovations and R&D unceasingly and has accumulated years of experiences in hardware and software design, manufacturing and entrepreneurship. After a successful startup working with metrology, quality assurance and information technology, CERTI has evolved to several areas delivering the best quality and focusing on the costumer priorities. CERTI is a national wide institution with three branches strategically placed on: Manaus (North), Brasilia (National District Capital in Middle-West) and Florianopolis (South). They create a perfect partnership for the development of products, researches and consulting services in the following areas: industrial metrology, instrumentation and automation, mechatronics, quality assurance, innovative entrepreneurship, industrial manufacturing, digital convergence, edutainment sustainable energy and green economy. CERTI has played a key role on the introduction of many successful innovation product and services like: - The Brazilian electronic voting machine, - New nation wide educational technologies - The Brazilian Digital TV System.

Live classes from the best University in Latin America, for you to watch wherever you want.

A Forest é uma Venture Builder focada em inovação no setor Florestal e Ambiental brasileiro. Nossa missão é impactar o mercado florestal e ambiental através da inovação em toda cadeia de negócio. Para isto, vamos atrair e selecionar startups nas fases de Validação e Crescimento, aplicar nossa metodologia de Venture Builder 4.0 e assegurar não apenas a sobrevivência, mas também o sucesso destas startups. Após quase 50 anos de relevantes serviços prestados ao setor Florestal, a SIF – Sociedade de Investigações Florestais encontrou na FCJ Participações (maior Venture Builder da América Latina) o parceiro ideal para expandir sua atuação e tornar-se sócia estratégica de empresas inovadoras. Agimos para permitir aos Founders focarem no desenvolvimento do Produto e apoiamos todas as outras áreas: marketing, jurídico, gente, financiamento e etc, sempre alinhados ao melhor interesse do captable da Startup, fator crítico de sucesso.

20/20 GeneSystems (‘20/20’) was founded in May of 2000 to develop and promote an innovative proteomics product line that provides drug companies, biodefense specialists and life scientists with new tools for protein analysis. Our headquarters are in the heart of the biotechnology corridor in Rockville, Maryland in close proximity to the National Institutes of Health with which we have extensive collaborations. 20/20 GeneSystems develops and commercializes innovative, proprietary diagnostics tests that aid in the fight against cancer. These tests generally fall into two categories: Personalized Medicine: Our patented platform technology for measuring biomarkers in tumors is highly unique in that it combines the visual advantages of classical pathology with the multiplex capabilities needed as a result of genomics and proteomics. This technology is now being used to develop tests to predict responses to several new targeted therapies for kidney and lung cancer. Early detection of lung cancer: 20/20 is developing a blood test for the early detection of lung cancer. This product will be used for screening smokers and former smokers to pre-select or enrich the patient population to receive annual CT scanning long before the disease becomes symptomatic. Biological Detection: 20/20 is on the leading edge of developing technologies to help in the detection of biological toxins.